NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)

This announcement encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing clinical studies.

Diseases chosen for study

credit: Top News


should be based on the NINDS strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm).
Related Programs

Extramural Research Programs in the Neurosciences and Neurological Disorders

Department of Health and Human Services



Who's Eligible





Obtain Full Opportunity Text:
https://grants.nih.gov/grants/guide/pa-files/PAR-25-133.html

Additional Information of Eligibility:
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.

Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/pa-files/PAR-25-133.html

Contact:


Agency Email Description:
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.

Agency Email:


Date Posted:
2024-11-12

Application Due Date:


Archive Date:
2027-10-11


301 Moved Permanently

Moved Permanently

The document has moved here.



More Federal Domestic Assistance Programs


Lead-Based Paint Hazard Control in Privately-Owned Housing (Recovery Act Funded) | Veterans Business Development | Chafee Education and Training Vouchers Program (ETV) | Special International Exchange Grant Programs | Semiconductor Chip Protection Service |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2025 Copyright Michael Saunders